PharmEasy's parent company, API Holdings, just reported a major turnaround in FY26. Revenue is up, EBITDA is positive, and Thyrocare is leading the way. But one big challenge still remains. More on the video.
PharmEasy's parent company, API Holdings, just reported a major turnaround in FY26. Revenue is up, EBITDA is positive, and Thyrocare is leading the way. But one big challenge still remains. More on the video.